Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 28 October 1988:
Vol. 242. no. 4878, pp. 580 - 583
DOI: 10.1126/science.2972065
Prev | Table of Contents | Next

Articles

Science, Vol 242, Issue 4878, 580-583
Copyright © 1988 by American Association for the Advancement of Science

articles

Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry

A Takeda, CU Tuazon, and FA Ennis

Department of Medicine, University of Massachusetts Medical School, Worcester 01655.

Monocytes and macrophages, which may play a central role in the pathogenesis of infection with human immunodeficiency virus type 1 (HIV-1), express the CD4 molecule and Fc receptors (FcR) for immunoglobulin G (IgG). To explore the possibility that FcR mediate HIV-1 infection of monocytes, studies were conducted with the human monocytic cell line U937. These cells were exposed to HIV-1 complexed with various concentrations of serum from HIV-1 antibody-positive individuals and monitored for HIV-1 replication. Serum samples from antibody-negative normal individuals did not affect virus yields. High concentrations of antibody-positive sera showed virus-neutralizing activity; however, cells infected with HIV-1 in the presence of antibody-positive sera at subneutralizing concentrations significantly enhanced virus replication. This infection enhancement was blocked by heat-aggregated gamma-globulin. Moreover, the IgG fraction from an HIV-1 antibody-positive serum enhanced HIV-1 infection at the same serum dilution equivalents. In contrast, IgG-F(ab')2 did not enhance HIV-1 infection but showed neutralizing activity with HIV-1. These results are compatible with the concept of FcR-mediated infection enhancement and suggest that this immunological response to HIV-1, instead of protecting the host, potentially facilitates the infection.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Utilization of Immunoglobulin G Fc Receptors by Human Immunodeficiency Virus Type 1: a Specific Role for Antibodies against the Membrane-Proximal External Region of gp41.
L. G. Perez, M. R. Costa, C. A. Todd, B. F. Haynes, and D. C. Montefiori (2009)
J. Virol. 83, 7397-7410
   Abstract »    Full Text »    PDF »
Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response..
I. D. Iankov, M. Pandey, M. Harvey, G. E. Griesmann, M. J. Federspiel, and S. J. Russell (2006)
J. Virol. 80, 8530-8540
   Abstract »    Full Text »    PDF »
Innate and Adaptive Mucosal Immunity in Protection against HIV Infection.
L.A. Bergmeier and T. Lehner (2006)
Advances in Dental Research 19, 21-28
   Abstract »    Full Text »    PDF »
Evaluation of live feline immunodeficiency virus vaccines with modified antigenic properties.
S. Broche-Pierre, J. Richardson, A. Moraillon, and P. Sonigo (2005)
J. Gen. Virol. 86, 2495-2506
   Abstract »    Full Text »    PDF »
Oxygen-Sensitive Kv Channel Gene Transfer Confers Oxygen Responsiveness to Preterm Rabbit and Remodeled Human Ductus Arteriosus: Implications for Infants With Patent Ductus Arteriosus.
B. Thebaud, E. D. Michelakis, X.-C. Wu, R. Moudgil, M. Kuzyk, J. R.B. Dyck, G. Harry, K. Hashimoto, A. Haromy, I. Rebeyka, et al. (2004)
Circulation 110, 1372-1379
   Abstract »    Full Text »    PDF »
Preferential Expression and Function of Voltage-Gated, O2-Sensitive K+ Channels in Resistance Pulmonary Arteries Explains Regional Heterogeneity in Hypoxic Pulmonary Vasoconstriction: Ionic Diversity in Smooth Muscle Cells.
S. L. Archer, X.-C. Wu, B. Thebaud, A. Nsair, S. Bonnet, B. Tyrrell, M. S. McMurtry, K. Hashimoto, G. Harry, and E. D. Michelakis (2004)
Circ. Res. 95, 308-318
   Abstract »    Full Text »    PDF »
Live, Attenuated Coronavirus Vaccines through the Directed Deletion of Group-Specific Genes Provide Protection against Feline Infectious Peritonitis.
B. J. Haijema, H. Volders, and P. J. M. Rottier (2004)
J. Virol. 78, 3863-3871
   Abstract »    Full Text »    PDF »
Antibody-mediated growth of infectious salmon anaemia virus in macrophage-like fish cell lines.
T. Joseph, M. T. Kibenge, and F. S. B. Kibenge (2003)
J. Gen. Virol. 84, 1701-1710
   Abstract »    Full Text »    PDF »
Fc{gamma} Receptor-Mediated Suppression of Human Immunodeficiency Virus Type 1 Replication in Primary Human Macrophages.
D. Perez-Bercoff, A. David, H. Sudry, F. Barre-Sinoussi, and G. Pancino (2003)
J. Virol. 77, 4081-4094
   Abstract »    Full Text »    PDF »
Lymphoid activation: a confounding factor in AIDS vaccine development?.
J. Richardson, S. Broche, S. Baud, T. Leste-Lasserre, F. Femenia, D. Levy, A. Moraillon, G. Pancino, and P. Sonigo (2002)
J. Gen. Virol. 83, 2515-2521
   Abstract »    Full Text »    PDF »
The Mechanism(s) of Hypoxic Pulmonary Vasoconstriction: Potassium Channels, Redox O2 Sensors, and Controversies.
S. Archer and E. Michelakis (2002)
Physiology 17, 131-137
   Abstract »    Full Text »    PDF »
Comparison of Human Immunodeficiency Virus (HIV)-Specific Infection-Enhancing and -Inhibiting Antibodies in AIDS Patients.
R. A. Subbramanian, J. Xu, E. Toma, R. Morisset, E. A. Cohen, J. Menezes,, and A. Ahmad (2002)
J. Clin. Microbiol. 40, 2141-2146
   Abstract »    Full Text »    PDF »
O2 sensing is preserved in mice lacking the gp91 phox subunit of NADPH oxidase.
S. L. Archer, H. L. Reeve, E. Michelakis, L. Puttagunta, R. Waite, D. P. Nelson, M. C. Dinauer, and E. K. Weir (1999)
PNAS 96, 7944-7949
   Abstract »    Full Text »    PDF »
Redox and Activation Status of Monocytes from Human Immunodeficiency Virus-Infected Patients: Relationship with Viral Load.
C. Elbim, S. Pillet, M. H. Prevost, A. Preira, P. M. Girard, N. Rogine, H. Matusani, J. Hakim, N. Israel, and M. A. Gougerot-Pocidalo (1999)
J. Virol. 73, 4561-4566
   Abstract »    Full Text »
Gag Protein Epitopes Recognized by CD4+ T-Helper Lymphocytes from Equine Infectious Anemia Virus-Infected Carrier Horses.
S. M. Lonning, W. Zhang, and T. C. McGuire (1999)
J. Virol. 73, 4257-4265
   Abstract »    Full Text »
The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens.
N. Ferguson, R. Anderson, and S. Gupta (1999)
PNAS 96, 790-794
   Abstract »    Full Text »    PDF »
An Envelope Modification That Renders a Primary, Neutralization-Resistant Clade B Human Immunodeficiency Virus Type 1 Isolate Highly Susceptible to Neutralization by Sera from Other Clades.
L. Stamatatos and C. Cheng-Mayer (1998)
J. Virol. 72, 7840-7845
   Abstract »    Full Text »    PDF »
Cytosolic Gag p24 as an Index of Productive Entry of Human Immunodeficiency Virus Type 1.
V. Marechal, F. Clavel, J. M. Heard, and O. Schwartz (1998)
J. Virol. 72, 2208-2212
   Abstract »    Full Text »    PDF »
Enhanced Virus Clearance by Early Inducible Lymphocytic Choriomeningitis Virus-Neutralizing Antibodies in Immunoglobulin-Transgenic Mice.
P. Seiler, U. Kalinke, T. Rulicke, E. M. Bucher, C. Bose, R. M. Zinkernagel, and H. Hengartner (1998)
J. Virol. 72, 2253-2258
   Abstract »    Full Text »    PDF »
Antibody Binding to Individual Short Consensus Repeats of Decay-Accelerating Factor Enhances Enterovirus Cell Attachment and Infectivity.
D. R. Shafren, D. J. Dorahy, R. F. Thorne, T. Kinoshita, R. D. Barry, and G. F. Burns (1998)
J. Immunol. 160, 2318-2323
   Abstract »    Full Text »    PDF »
Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism.
J. Sixbey and Q. Yao (1992)
Science 255, 1578-1580
   Abstract »    PDF »
Antiretroviral Chemotherapy of Human Immunodeficiency Virus Infections Other Than With Azidothymidine.
M. K. Sachs (1992)
Arch Intern Med 152, 485-501
   Abstract »    PDF »
The Safety and Immunogenicity of a Human Immunodeficiency Virus Type 1 (HIV-1) Recombinant gp160 Candidate Vaccine in Humans.
R. Dolin, B. S. Graham, S. B. Greenberg, C. O. Tacket, R. B. Belshe, K. Midthun, M. L. Clements, G. J. Gorse, B. W. Horgan, R. L. Atmar, et al. (1991)
Ann Intern Med 114, 119-127
   Abstract »    PDF »
Human CD4 binds immunoglobulins.
P Lenert, D Kroon, H Spiegelberg, E. Golub, and M Zanetti (1990)
Science 248, 1639-1643
   Abstract »    PDF »
The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells.
J Homsy, M Meyer, M Tateno, S Clarkson, and J. Levy (1989)
Science 244, 1357-1360
   Abstract »    PDF »
Human Immunodeficiency Viruses and the Pathogenesis of AIDS.
J. A. Levy (1989)
JAMA 261, 2997-3006
   Abstract »    PDF »
Prospects for Prevention of and Early Intervention Against HIV.
D. P. Bolognesi (1989)
JAMA 261, 3007-3013
   Abstract »    PDF »
Secretory responses of intact glomus cells in thin slices of rat carotid body to hypoxia and tetraethylammonium.
R. Pardal, U. Ludewig, J. Garcia-Hirschfeld, and J. Lopez-Barneo (2000)
PNAS 97, 2361-2366
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)